Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
about
Induced Stem Cells as a Novel Multiple Sclerosis TherapyImmunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapyDynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.The stem cell secretome and its role in brain repair.Could cord blood cell therapy reduce preterm brain injury?Mesenchymal stem cell-based therapy in a mouse model of experimental autoimmune encephalomyelitis (EAE)Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitisHuman adult stem cells derived from adipose tissue and bone marrow attenuate enteric neuropathy in the guinea-pig model of acute colitis.Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.Updates in the pathophysiological mechanisms of Parkinson's disease: Emerging role of bone marrow mesenchymal stem cellsTransplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.Amelioration of experimental autoimmune encephalomyelitis through transplantation of placental derived mesenchymal stem cells.Systemic Administration of Induced Neural Stem Cells Regulates Complement Activation in Mouse Closed Head Injury Models.Cell-based reparative therapies for multiple sclerosis.Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies.Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies.The regenerative role of adipose-derived stem cells (ADSC) in plastic and reconstructive surgery.Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy.Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal FibrosisHuman ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis.The secretome of periodontal ligament stem cells from MS patients protects against EAE.Distinct in vitro properties of embryonic and extraembryonic fibroblast-like cells are reflected in their in vivo behavior following grafting in the adult mouse brain.Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.Effects of umbilical cord blood cells, and subtypes, to reduce neuroinflammation following perinatal hypoxic-ischemic brain injury.Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury.Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE.Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review
P2860
Q28081780-892D689C-5FF8-4BD4-84A9-F6DB3211C839Q29994669-3DE9291B-4235-4BB0-AF20-2971E806906AQ30538835-48519F2E-E278-4A6A-9152-A91CD3CD266CQ33771698-DA5F1BFE-0E67-4D81-ADF2-589B64169594Q34312137-DAFC8727-219A-4E2E-8C56-CAA3C0677CFAQ35213818-64A32C9F-2A4F-438B-8225-C85426D5D7B9Q35373250-EB28FAF8-EECB-40F6-94AC-D77668C68881Q35689857-77EB4CCB-98E2-4C67-86C5-33ED736E90C6Q36361561-1B7B488E-6C82-4FCA-A35F-8E817147D913Q36419634-D900163D-A8AB-4E7C-8D90-2F3964C6F500Q36700629-9DAF763A-CCA6-409A-A51F-9061F20366C3Q36727515-D7EFF802-A60E-4664-812A-5ADC2510C5D2Q37521318-41F9F756-E7A0-423B-8242-E9E49EAB699BQ37635109-5C5AC32B-19DB-4FF1-B808-E4BB5D945773Q37739537-C97AAD59-14E1-4BE1-AE66-BCA4B82FD350Q38147012-FB1ADB1F-CF1F-4867-845F-3E63FBC5EA88Q38186029-D6CBCD15-9870-401D-869B-71164C20C4C0Q38538932-9D48A0AD-C096-4A1A-97DA-FE6769005070Q38539382-12CC5AA6-5129-489C-8F4C-C134DAEBCB52Q38718917-764F930C-47B3-40F4-B2F9-01DC016F6E23Q39114043-51FC41BC-CA57-415C-A5DD-09097AB2EEDDQ41436644-838431D5-5E10-4EDA-9057-EDF5202A14E5Q41635867-5E7C6C3A-1666-4BFE-8493-1E7B32B3A6DEQ41900937-752BEC75-27FD-406E-842A-1E53598BFC5AQ42009083-0EBA426E-586B-41BD-9120-5A2EA9414C90Q44634688-A1B4332D-7F55-4E2D-A338-3239E32DD7F7Q45862169-D0BDB8BA-4614-4AE4-9D8F-7893E40DE400Q49900414-B4864C2F-0D27-4A35-8568-946E9BD94C5AQ49961729-46883D10-03A9-4757-9F32-FDF704965D48Q53570871-3FC5F955-1953-45A9-8F85-F25104A0D682Q54565698-97FA0442-4B13-4F40-AE32-6502D8DD1794Q55026303-9DA49F02-7E05-4E21-9FE2-23C75D00DE4AQ55097633-7A3334DE-7055-4133-8019-6587C1778C60Q57538743-60AF42C9-7117-47E6-9A71-D943ABC4A880
P2860
Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Distinct immunomodulatory and ...... s in autoimmune demyelination.
@en
Distinct immunomodulatory and ...... s in autoimmune demyelination.
@nl
type
label
Distinct immunomodulatory and ...... s in autoimmune demyelination.
@en
Distinct immunomodulatory and ...... s in autoimmune demyelination.
@nl
prefLabel
Distinct immunomodulatory and ...... s in autoimmune demyelination.
@en
Distinct immunomodulatory and ...... s in autoimmune demyelination.
@nl
P2093
P50
P356
P1433
P1476
Distinct immunomodulatory and ...... ls in autoimmune demyelination
@en
P2093
Ashley Emerson-Webber
Christopher Siatskas
Daniel Layton
Daniella Herszfeld
Guizhi Sun
Leon Moussa
Nadege Veron
Natalie L Payne
P304
P356
10.3727/096368912X657620
P577
2012-10-04T00:00:00Z